Medicare Monday: Expanding Access to Medicare GLP-1Bridge Weight-Loss Drugs

Here’s How the New Bridge Program Works

If you’ve heard that Medicare is now covering GLP-1 medications for weight loss, there’s some truth to that, but there’s also a very important catch. Medicare has not simply opened coverage of weight-loss medications to everyone. Instead, the Centers for Medicare & Medicaid Services (CMS) launched a new program called the Medicare GLP-1 Bridge, which gives certain people with Medicare Part D access to specific GLP-1 weight-management medications for $50 per month if they meet the program’s eligibility requirements. The program began July 1, 2026, and CMS has now extended it through December 31, 2027. That makes this a Medicare change worth understanding.

What Is the Medicare GLP-1 Bridge?

For years, Medicare generally could not cover medications when they were prescribed solely for weight loss. Some GLP-1 medications could already be covered under Medicare Part D when prescribed for certain other FDA approved medical indications such as type 2 diabetes.

The Medicare GLP-1 Bridge creates another pathway.

It is a temporary CMS demonstration program designed to give eligible Medicare Part D beneficiaries access to certain GLP-1 medications when they are being prescribed to reduce excess body weight and maintain weight reduction. One especially important point: The Bridge operates outside the normal Medicare Part D benefit and payment system. Your Medicare drug plan does not have to choose to participate in the Bridge for you to potentially qualify.

Which GLP-1 Medications Are Included?

According to CMS, the medications currently eligible through the Medicare GLP-1 Bridge for weight management are:

• Wegovy® — injection and tablets

• Zepbound® — KwikPen formulation

• Foundayo®

The list could change as the program develops, so beneficiaries should verify current information before assuming a particular medication is covered.

How Much Will You Pay?

For an eligible beneficiary, the cost through the Medicare GLP-1 Bridge is $50 for a monthly supply. But there is an unusual Medicare detail here that is easy to miss. Because the Bridge operates outside the regular Part D benefit: The $50 does not count toward your Part D deductible or your annual Part D out-of-pocket costs. The Part D deductible also does not apply to a drug received through the Bridge, and beneficiaries receiving Extra Help do not receive an additional subsidy on the $50 Bridge copay.

Who Qualifies for the Medicare GLP-1 Bridge?

This is where the headlines can be misleading.

Having Medicare does not automatically qualify someone for a $50 GLP-1. You generally must be enrolled in an eligible Medicare Part D prescription drug plan or a qualifying Medicare Advantage plan that includes Part D coverage, and your healthcare provider must submit a prior authorization showing that you meet the clinical requirements. CMS currently provides several pathways for meeting the clinical criteria.

You may qualify if you had:

A BMI of 35 or higher when GLP-1 therapy was initiated OR a BMI of 30 or higher plus at least one of the following:

• Heart failure with preserved ejection fraction

• Uncontrolled high blood pressure despite treatment with two blood pressure medications

• Chronic kidney disease stage 3a or higher

  
  

OR

A BMI of 27 or higher plus at least one of the following:

• Prediabetes

• Previous heart attack

• Previous stroke

• Symptomatic peripheral artery disease

The medication must also be prescribed for reducing excess body weight and maintaining weight reduction along with ongoing lifestyle changes involving nutrition and physical activity.

What If Your BMI Has Already Gone Down Because You're Taking a GLP-1?

This is an interesting provision that may matter to people who are already taking one of these medications. CMS looks at whether you met the clinical criteria when you started GLP-1 therapy, not necessarily your BMI today. For example, CMS explains that someone who began treatment with a BMI of 37 but later reduced their BMI to 34 could potentially satisfy the BMI requirement based on their BMI when treatment began. Their provider would need to attest to that information during the prior authorization process.

What About Ozempic or Mounjaro for Diabetes?

This is another important distinction. The Medicare GLP-1 Bridge is intended for eligible people seeking GLP-1 treatment for weight management, who otherwise do not have a Part D covered indication. Conditions such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, and certain MASH liver disease indications may already qualify for GLP-1 coverage through Medicare Part D.

If a GLP-1 is being prescribed for an indication that Medicare Part D can already cover, the beneficiary should generally obtain the medication through their Part D plan rather than through the Bridge. In other words, two people taking similar medications could have very different Medicare coverage depending on why the medication was prescribed.

What Happens in 2027?

Originally, the Medicare GLP-1 Bridge was intended to help transition Medicare toward a larger CMS initiative known as the BALANCE Model — Better Approaches to Lifestyle and Nutrition for Comprehensive Health.

CMS has since changed that timeline. The Medicare portion of BALANCE will not launch in 2027 as originally planned. Instead, CMS extended the Medicare GLP-1 Bridge through December 31, 2027 while it gathers additional information and evaluates potential implementation of BALANCE within Medicare Part D. So for Medicare beneficiaries, the Bridge is the program to watch during both 2026 and 2027.

How Do You Apply?

You don't simply enroll in the Bridge yourself like you would enroll in a Medicare plan.

Your prescribing healthcare provider plays an important role because a prior authorization must be submitted demonstrating that you meet the Bridge's clinical requirements. Once the initial fill is approved, CMS says subsequent refills generally do not require another prior authorization unless you switch to a different covered GLP-1 medication. You can also check information directly through Medicare at Medicare.gov/glp1bridge or call 1-800-MEDICARE (1-800-633-4227).

Why This Matters When Choosing Medicare Coverage

One thing I always remind people is that prescription drug coverage is about much more than simply looking at the premium of a Medicare plan. Your medications, diagnoses, formulary, pharmacy, prior-authorization requirements and eligibility for special Medicare programs can all affect what you ultimately pay. The Medicare GLP-1 Bridge is a good example. A medication that may have previously been financially out of reach for someone could now be available for $50 per month, but only when that individual meets very specific requirements.

And someone who doesn't qualify for the Bridge may have completely different coverage through their Medicare Part D plan depending on the medical reason the GLP-1 was prescribed. That's why Medicare coverage should always be reviewed based on your individual healthcare and prescription needs, rather than simply choosing the plan that worked well for a friend or family member.

Need Help Understanding Your Medicare Options?

As a licensed independent health insurance agent, I help people understand their Medicare choices, including Medicare Advantage, Medicare Supplement and prescription drug coverage. If you're wondering how your medications fit into your Medicare coverage, we can review your options together.

Cheryl Lockhart

Licensed Health Insurance Agent

NPN# 21646703

(656)228-4979

By calling this number or providing your information you agree to speak with a licensed insurance agent about Medicare Advantage, Part D Prescription Drug Plans or Medicare Supplements.  Not affiliated with any government agency including Medicare.